您的位置: 首页 > 农业专利 > 详情页

Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy
专利权人:
The U.S.A., as represented by the Secretary, Department of Health and Human Services;LentigenTechnology, Inc.
发明人:
Rimas J. Orentas,Dina Schneider,Boro Dropulic,Dimiter S. Dimitrov,Zhongyu Zhu
申请号:
US16773379
公开号:
US20200155661A1
申请日:
2020.01.27
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Chimeric antigen receptors (CARs) containing CD22 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the CARs are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making CAR T cells are also disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充